Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,308,410
+$2,053,623 QoQ
Shares Held
8,504
+567.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#353
of 844 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIL Ltd holds $1,288,341,636 across 16 Diagnostics & Research names. NTRA ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,323,444 | $442,569,612 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
789,329 | $395,737,987 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
818,997 | $158,246,599 | |
| 4 | TWST |
Twist Bioscience Corp
|
641,096 | $65,955,956 | |
| 5 | DGX |
Quest Diagnostics Inc
|
251,976 | $53,406,312 | |
| 6 | QGEN |
Qiagen N.V.
|
1,290,558 | $50,460,817 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
39,124 | $49,981,301 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
111,048 | $25,184,575 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,308,410 | 8,504 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $254,787 | 1,274 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||